Impact of Digital Therapeutic on Metabolic Parameters
- Conditions
- Diabetes Mellitus, Type 2Insulin ResistancePrediabetic StateObesity
- Interventions
- Device: VitadioBehavioral: Conventional high-intensity lifestyle intervention program
- Registration Number
- NCT04573296
- Lead Sponsor
- Vitadio s.r.o.
- Brief Summary
The purpose of this prospective randomized controlled study is to evaluate the impact of a six-month digitally administered behavioral change program on body weight, glycemic control and other metabolic parameters in obese adults with insulin resistance, prediabetes or type 2 diabetes as compared to conventional high-intensity lifestyle intervention program administered at a specialized department of a university hospital.
- Detailed Description
In this prospective randomized clinical study, obese adults with insulin resistance, prediabetes or diabetes mellitus type 2, patients of the Department of Exercise Medicine and Cardiovascular Rehabilitation at the University Hospital Olomouc, are randomized to receive either Vitadio or a conventional 6-month high-intensity lifestyle intervention program at the clinic.
Vitadio is a mobile application delivering behavioral change program focused on lifestyle change and self-management. The program aims for strengthening patients autonomy with the goal to promote weight loss and improve metabolic health. The program includes personalized education, adaptive daily tasks and weekly goals, automated motivational and educational messaging, monitoring tools, recipes, peer-support group and one-on-one remote coaching. Personalization of the intervention is achieved by analyzing participant's interactions with the application.
The conventional therapy consists of 5 face-to-face nutrition/lifestyle education sessions (at baseline, at 1st, 2nd and 3rd month, and at month 6). Participants in the control group can use an online diary tool for recording meals with an option to receive remote feedback on their diet from the educator. In addition, all participants undergo a regular medical assessment at the clinic (baseline, month 3, month 6).
The aim of the study is to assess feasibility and efficacy of digitally administered intervention by comparing evolution of weight, physical fitness, laboratory measures of metabolic health, blood pressure and other outcomes.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- obesity with body mass index (BMI) above 30 kg/m^2
- insulin resistance or prediabetes or type 2 diabetes mellitus
- acess to device with internet access (notebook, smartphone, tablet)
- willingness and ability to comply with all scheduled visits, laboratory tests, lifestyle considerations and other study procedures
- pregnancy
- steroid treatment
- type 2 diabetes mellitus on insulin therapy
- severe renal and/or hepatic impairment
- any impairments including mental and psychological or conditions which, in the opinion of the investigator, would seriously compromise the integrity of the study
- inability to understand, consent to, or comply with the study protocol for any reason, including inability to read or comprehend Czech language
- inability to comply with study procedures
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Participants using Vitadio Vitadio Participants in the intervention arm undergo a 6-month digitally administered behavioral change program Vitadio focused on lifestyle change and self-management. The program aims for strengthening patients autonomy with the goal to promote weight loss and improve metabolic health. The program includes personalized education, adaptive daily tasks and weekly goals, automated motivational and educational messaging, monitoring tools, recipes, peer-support group and one-on-one remote coaching. In addition, they undergo regular face-to-face medical assessment. Participants assigned to conventional high-intensity lifestyle intervention program Conventional high-intensity lifestyle intervention program Participants in the control group undergo a 6-month high-intensity lifestyle intervention program consisting of of 5 face-to-face nutrition/lifestyle education sessions. Participants can use an online diary tool for recording meals with an option to receive remote feedback on their diet from the educator. In addition, they undergo regular face-to-face medical assessment.
- Primary Outcome Measures
Name Time Method Change in body weight baseline, three months, six months comparison of baseline and end program body weight
- Secondary Outcome Measures
Name Time Method change in blood pressure baseline, three months, six months comparison of baseline, three-month and end-program blood pressure between groups
change in resting metabolic rate (RMR) baseline, three months, six months comparison of baseline, three-month and end-program resting metabolic rate assessed by indirect calorimetry between groups
change in cardiorespiratory fitness baseline, three months, six months comparison of baseline, three-month and end-program cardiorespiratory fitness assessed by spiroergometry between groups
change in liver function tests baseline, three months, six months comparison of baseline, three-month and end-program standard liver panel (ALT, AST, GGT, ALP) values between groups
change in haemoglobin A1c baseline, three months, six months comparison of baseline, three-month and end-program haemoglobin A1c values between groups
change in body composition baseline, three months, six months comparison of baseline, three-month and end-program body composition assessed with the InBody bioelectrical impedance analysis device between groups
change in body mass index (BMI) baseline, three months, six months comparison of baseline, three-month and end-program body mass index (BMI) between groups
change in insulin resistance baseline, three months, six months comparison of baseline, three-month and end-program insulin resistance quantified by HOMA-IR between groups
change in blood glucose baseline, three months, six months comparison of baseline, three-month and end-program blood glucose values between groups
change in adherence to lifestyle intervention baseline, three months, six months comparison of baseline, three-month and end-program adherence to healthy lifestyle assigned both by subjective (adapted questionnaire) and objective (program usage frequency, attrition) measures between groups
change in lipid parameters (total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides) baseline, three months, six months comparison of baseline, three-month and end-program levels of total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides between groups
change in waist circumference baseline, three months, six months comparison of baseline, three-month and end-program waist circumference between groups
change in fasting insulin levels baseline, three months, six months comparison of baseline, three-month and end-program fasting insulin levels between groups
Trial Locations
- Locations (1)
University Hospital Olomouc
🇨🇿Olomouc, Czechia